Biblio Discovery — Demo Discovery Service

175 results for "Gandy Sam"

Showing 1–20 · 0.11 seconds · RSS

  1. Journal Article Full text

    Alzheimer's Disease: New Data Highlight Nonneuronal Cell Types and the Necessity for Presymptomatic Prevention Strategies

    Gandy, Sam

    Biol Psychiatry · 2013 · English · PubMed Central

    Despite compelling genetic evidence indicating that cerebral amyloidosis can be, at least sometimes, the primary cause of Alzheimer's disease (AD), clinical trials for symptomatic AD with amyloid-reducing agents have succeeded at target engagement but failed to cause clinical benefit. In a landmark…

  2. Journal Article Full text

    Prevention is better than cure

    Gandy, Sam

    Nature · 2011 · English · PubMed Central

    Attempts to reduce amyloid-β in the brain have yet to show clinical benefits. Starting treatment early is the best hope, says Sam Gandy.

  3. Journal Article Full text

    Testing the amyloid hypothesis of Alzheimer’s in vivo

    Gandy, Sam

    Lancet Neurol · 2010 · English · PubMed Central

  4. Journal Article Full text

    The role of cerebral amyloid β accumulation in common forms of Alzheimer disease

    Gandy, Sam

    J Clin Invest · 2005 · English · PubMed Central

    For approximately 80 years following Alzheimer’s description of the disease that bears his name, a gulf divided researchers who believed that extracellular deposits of the amyloid β (Aβ) peptide were pathogenic from those who believed that the deposits were secondary detritus. Since 1990, the…

  5. Journal Article

    Authors' Reply

    Gandy Sam; Petanceska Suzana

    PLoS Medicine, Vol. 2 No. 3 · 2005 · English · DOAJ Scopus

  6. Journal Article Full text

    Evidence that an APOE ε4 'double whammy' increases risk for Alzheimer's disease

    Caesar Ina; Gandy Sam

    BMC Medicine, Vol. 10 No. 1 · 2012 · English · DOAJ Scopus

    Abstract Temporal lobe epilepsy (TLE) is associated with some of the same neuropathological features as those reported for early stages of typical Alzheimer's disease (AD). The APOE ε4 allele is associated with a gene-dose-dependent increase in AD risk and in the severity of amyloid-β (Aβ)…

    Also available at: PubMed Central

  7. Journal Article Full text

    Authors' Reply

    Gandy, Sam; Petanceska, Suzana

    PLoS Med · 2005 · English · PubMed Central

  8. Journal Article Full text

    Solanezumab—prospects for meaningful interventions in AD?

    Gandy, Sam; Sano, Mary

    Nat Rev Neurol · 2015 · English · PubMed Central

    A treatment trial of the monoclonal anti-amyloid antibody solanezumab showed slight benefits in people with dementia due to mild Alzheimer disease. Drug effects on several neuropsychological testing outcomes were statistically significant, but the effect sizes were unlikely to manifest as…

  9. Journal Article Full text

    2012: the year in dementia

    Gandy, Sam; DeKosky, Steven T

    Lancet Neurol · 2013 · English · PubMed Central

  10. Journal Article Full text

    Amyloid-β Oligomers: Possible Roles as Key Neurotoxins in Alzheimer’s Disease

    Lublin, Alex L.; Gandy, Sam

    Mt Sinai J Med · 2010 · English · PubMed Central

    Alzheimer’s disease is the most common form of senile dementia. Although the amyloid-β peptide was identified in 1984 as the major constituent of the senile plaques that characterize the disease, accumulating evidence indicates that the plaque density does not correspond well to the concurrent…

  11. Journal Article Full text

    Chromatin plasticity and the pathogenesis of Huntington disease

    Ehrlich, Michelle E.; Gandy, Sam

    Proc Natl Acad Sci U S A · 2011 · English · PubMed Central

  12. Journal Article Full text

    Latrepirdine (Dimebon(®)), a potential Alzheimer therapeutic, regulates autophagy and neuropathology in an Alzheimer mouse model

    Steele, John W.; Gandy, Sam

    Autophagy · 2013 · English · PubMed Central

    Alzheimer disease (AD) is a form of neurodegeneration that develops over the course of multiple decades and as a result of the accumulation of the pathogenic amyloid-β (Aβ) peptide, also known as A4. In late-stage AD, failure of autophagic clearance results in neuronal cell bodies that are almost…

  13. Journal Article Full text

    Toward the Treatment and Prevention of Alzheimer’s Disease: Rational Strategies and Recent Progress

    Gandy, Sam; DeKosky, Steven T.

    Annu Rev Med · 2013 · English · PubMed Central

    Alzheimer’s disease (AD) is the major cause of late-life brain failure. In the past 25 years, autosomal dominant forms of AD were found to be primariy attributable to mutations in one of two presenilins, polytopic proteins that contain the catalytic site of the γ-secretase protease that releases…

  14. Journal Article Full text

    Breaking Up (Amyloid) Is Hard to Do

    Gandy, Sam; Heppner, Frank L

    PLoS Med · 2005 · English · PubMed Central

    Gandy and Heppner discuss the implications of a new animal study on our understanding of the pathogenesis and treatment of Alzheimer disease.